Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CAO Ryan Bartolucci sold 1,904 shares of Tempus AI stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $142,133.60. Following the transaction, the chief accounting officer directly owned 45,895 shares in the company, valued at approximately $3,426,061.75. This trade represents a 3.98% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Tempus AI Stock Up 4.7%
NASDAQ:TEM traded up $3.43 on Thursday, hitting $76.71. 15,581,883 shares of the company's stock traded hands, compared to its average volume of 12,600,730. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. Tempus AI, Inc. has a 1 year low of $31.36 and a 1 year high of $91.45. The firm has a 50-day moving average price of $63.48 and a 200-day moving average price of $58.98. The company has a market cap of $13.33 billion, a PE ratio of -64.46 and a beta of 4.98.
Tempus AI (NASDAQ:TEM - Get Free Report) last released its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company had revenue of $314.64 million for the quarter, compared to analysts' expectations of $296.84 million. During the same quarter in the previous year, the business posted ($6.86) EPS. The business's revenue for the quarter was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. Equities analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several brokerages recently commented on TEM. BTIG Research boosted their price target on Tempus AI from $75.00 to $85.00 and gave the company a "buy" rating in a research note on Wednesday. Bank of America boosted their price target on Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Piper Sandler reissued a "neutral" rating on shares of Tempus AI in a research note on Friday, August 8th. Needham & Company LLC reissued a "buy" rating and issued a $70.00 price target on shares of Tempus AI in a research note on Friday, August 8th. Finally, Morgan Stanley boosted their price target on Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a research note on Tuesday, August 12th. Six investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $67.64.
View Our Latest Analysis on Tempus AI
Institutional Investors Weigh In On Tempus AI
A number of large investors have recently added to or reduced their stakes in the stock. ARK Investment Management LLC boosted its position in Tempus AI by 35.9% during the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company's stock worth $361,867,000 after purchasing an additional 1,981,755 shares during the period. Vanguard Group Inc. boosted its position in Tempus AI by 6,247.5% during the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock worth $289,204,000 after purchasing an additional 5,900,668 shares during the period. Nikko Asset Management Americas Inc. boosted its position in Tempus AI by 31.5% during the first quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company's stock worth $205,401,000 after purchasing an additional 1,021,460 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its position in Tempus AI by 31.4% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock worth $205,284,000 after purchasing an additional 1,016,384 shares during the period. Finally, Frontier Capital Management Co. LLC boosted its position in Tempus AI by 236.2% during the fourth quarter. Frontier Capital Management Co. LLC now owns 943,718 shares of the company's stock worth $31,860,000 after purchasing an additional 663,018 shares during the period. Institutional investors own 24.22% of the company's stock.
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.